Cooley-Led Electra Therapeutics Prices Upsized $350M IPO
Cooley LLP-advised Electra Therapeutics, a venture-backed biotech firm developing antibodies for immune diseases and cancer, began trading Friday after raising $350 million in an upsized IPO....To view the full article, register now.
Already a subscriber? Click here to view full article